Premium Nahrungsergänzungsmittel | artgerecht

ACR/EULAR Classification Criteria Explained

The ACR/EULAR classification criteria are standardized frameworks used to uniformly categorize patients with rheumatic diseases for research and clinical purposes.

Regular tips about health Regular tips about health

Things worth knowing about "ACR/EULAR classification criteria"

The ACR/EULAR classification criteria are standardized frameworks used to uniformly categorize patients with rheumatic diseases for research and clinical purposes.

What are the ACR/EULAR Classification Criteria?

The ACR/EULAR classification criteria are jointly developed by the American College of Rheumatology (ACR) and the European Alliance of Associations for Rheumatology (EULAR). They provide standardized, reproducible frameworks for classifying patients with rheumatic diseases, primarily for use in clinical research and patient registries.

It is important to note that classification criteria are not the same as diagnostic criteria. While diagnostic criteria assist clinicians in identifying a disease in an individual patient, classification criteria are designed to ensure that clinical studies include well-defined, homogeneous patient populations.

Background and Development

ACR and EULAR regularly update their classification criteria to reflect advances in medical science. The development process typically involves:

Systematic literature reviews
Expert consensus procedures (Delphi methods)
Statistical validation in large patient cohorts
International expert panel voting

The final criteria are published in leading rheumatology journals such as Arthritis & Rheumatology and Annals of the Rheumatic Diseases.

Areas of Application

ACR/EULAR classification criteria have been established for a wide range of rheumatic and related conditions. The most widely used include:

Rheumatoid Arthritis (RA) – ACR/EULAR criteria 2010
Systemic Lupus Erythematosus (SLE) – ACR/EULAR criteria 2019
Spondyloarthritides (e.g. axial spondyloarthritis, psoriatic arthritis) – ASAS/EULAR and CASPAR criteria
Primary Sjogren syndrome – ACR/EULAR criteria 2016
Systemic Sclerosis (Scleroderma) – ACR/EULAR criteria 2013
Idiopathic Inflammatory Myopathies – ACR/EULAR criteria 2017
Gout and crystal arthropathies
Vasculitides (e.g. ANCA-associated vasculitis)

Structure of the Criteria

The structure of classification criteria varies by disease but typically includes:

Entry criteria: Mandatory prerequisites that must be met before the remaining criteria are applied (e.g., evidence of synovial inflammation in RA)
Score-based systems: Individual clinical, laboratory, or imaging findings are assigned point values; a patient is classified when a defined threshold is reached
Domain-based systems: Multiple disease domains (e.g. clinical features, serology, imaging) are weighted and scored together

Example: ACR/EULAR Criteria for Rheumatoid Arthritis (2010)

The 2010 Rheumatoid Arthritis classification criteria evaluate four domains with a maximum of 10 points:

Number and type of affected joints (0–5 points)
Serology (rheumatoid factor, anti-CCP antibodies; 0–3 points)
Acute phase reactants (CRP, ESR; 0–1 points)
Duration of symptoms (0–1 points)

A patient is classified as having Rheumatoid Arthritis when a total score of 6 or more out of 10 points is reached, provided alternative diagnoses have been excluded.

Difference Between Classification and Diagnosis

A common misconception is equating classification criteria with diagnostic criteria:

Classification criteria are designed for research. They ensure that clinical trials enroll only patients who, with high probability, have the defined disease.
Diagnostic criteria are used in routine clinical care and are often broader, capturing early or atypical presentations.

ACR and EULAR explicitly caution against using classification criteria as the sole basis for clinical diagnosis, as this can lead to misclassification.

Clinical Relevance

Although ACR/EULAR classification criteria are primarily research tools, they have a significant impact on clinical practice:

They underpin drug approval processes by regulatory bodies such as the EMA and FDA, as pivotal clinical trials are based on these criteria.
They support structured documentation in patient registries and quality assurance programs.
They promote international comparability of study results.
Clinicians frequently use them as a reference framework, even though they are formally not intended for individual diagnosis.

Updates and Evolution

ACR/EULAR criteria are periodically revised when new scientific insights – such as advances in biomarker research or imaging technology – require adaptation. Recent developments include the integration of ultrasound and MRI findings as well as novel biomarkers into existing criteria sets.

References

Aletaha D et al. - 2010 Rheumatoid Arthritis Classification Criteria: An American College of Rheumatology/European League Against Rheumatism Collaborative Initiative. Arthritis & Rheumatism, 2010.
Aringer M et al. - 2019 European League Against Rheumatism/American College of Rheumatology Classification Criteria for Systemic Lupus Erythematosus. Annals of the Rheumatic Diseases, 2019.
van den Berg R et al. - ASAS/EULAR recommendations for the management of ankylosing spondylitis. Annals of the Rheumatic Diseases, 2011.

Building Blocks for a Healthy Life

As an integrated manufacturer, we develop & produce evidence-based, patented, and non-patented formulations. We work exclusively with plant and natural extracts according to the strictest purity & quality standards.
The combination of science & modern technology with the laws of nature creates solutions consistently tailored to humans – for the highest good: health.